204 related articles for article (PubMed ID: 22553146)
1. Advanced glycation end product Nε-carboxymethyllysine induces endothelial cell injury: the involvement of SHP-1-regulated VEGFR-2 dephosphorylation.
Liu SH; Sheu WH; Lee MR; Lee WJ; Yi YC; Yang TJ; Jen JF; Pan HC; Shen CC; Chen WB; Tien HR; Sheu ML
J Pathol; 2013 Jun; 230(2):215-27. PubMed ID: 22553146
[TBL] [Abstract][Full Text] [Related]
2. Nε-carboxymethyllysine-mediated endoplasmic reticulum stress promotes endothelial cell injury through Nox4/MKP-3 interaction.
Lee WJ; Sheu WH; Liu SH; Yi YC; Chen WC; Lin SY; Liang KW; Shen CC; Yeh HY; Lin LY; Tsai YC; Tien HR; Lee MR; Yang TJ; Sheu ML
Free Radic Biol Med; 2014 Sep; 74():294-306. PubMed ID: 25014566
[TBL] [Abstract][Full Text] [Related]
3. Minodronate, a nitrogen-containing bisphosphonate, inhibits advanced glycation end product-induced vascular cell adhesion molecule-1 expression in endothelial cells by suppressing reactive oxygen species generation.
Yamagishi S; Matsui T; Nakamura K; Takeuchi M
Int J Tissue React; 2005; 27(4):189-95. PubMed ID: 16440584
[TBL] [Abstract][Full Text] [Related]
4. Advanced glycation end-product Nε-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes.
Wang Z; Jiang Y; Liu N; Ren L; Zhu Y; An Y; Chen D
Atherosclerosis; 2012 Apr; 221(2):387-96. PubMed ID: 22305260
[TBL] [Abstract][Full Text] [Related]
5. Glycation of vitronectin inhibits VEGF-induced angiogenesis by uncoupling VEGF receptor-2-αvβ3 integrin cross-talk.
Wang L; Zhang X; Pang N; Xiao L; Li Y; Chen N; Ren M; Deng X; Wu J
Cell Death Dis; 2015 Jun; 6(6):e1796. PubMed ID: 26111058
[TBL] [Abstract][Full Text] [Related]
6. The tyrosine phosphatase, SHP-1, is a negative regulator of endothelial superoxide formation.
Krötz F; Engelbrecht B; Buerkle MA; Bassermann F; Bridell H; Gloe T; Duyster J; Pohl U; Sohn HY
J Am Coll Cardiol; 2005 May; 45(10):1700-6. PubMed ID: 15893190
[TBL] [Abstract][Full Text] [Related]
7. Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products.
Xu B; Chibber R; Ruggiero D; Kohner E; Ritter J; Ferro A
FASEB J; 2003 Jul; 17(10):1289-91. PubMed ID: 12738813
[TBL] [Abstract][Full Text] [Related]
8. The alternative crosstalk between RAGE and nitrative thioredoxin inactivation during diabetic myocardial ischemia-reperfusion injury.
Liu Y; Qu Y; Wang R; Ma Y; Xia C; Gao C; Liu J; Lian K; Xu A; Lu X; Sun L; Yang L; Lau WB; Gao E; Koch W; Wang H; Tao L
Am J Physiol Endocrinol Metab; 2012 Oct; 303(7):E841-52. PubMed ID: 22829582
[TBL] [Abstract][Full Text] [Related]
9. Viscolin reduces VCAM-1 expression in TNF-α-treated endothelial cells via the JNK/NF-κB and ROS pathway.
Liang CJ; Wang SH; Chen YH; Chang SS; Hwang TL; Leu YL; Tseng YC; Li CY; Chen YL
Free Radic Biol Med; 2011 Oct; 51(7):1337-46. PubMed ID: 21767632
[TBL] [Abstract][Full Text] [Related]
10. Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.
Pala L; Cresci B; Manuelli C; Maggi E; Yamaguchi YF; Cappugi P; Rotella CM; Giannini S
Microvasc Res; 2005 Nov; 70(3):179-88. PubMed ID: 16271941
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathway.
Thallas-Bonke V; Thorpe SR; Coughlan MT; Fukami K; Yap FY; Sourris KC; Penfold SA; Bach LA; Cooper ME; Forbes JM
Diabetes; 2008 Feb; 57(2):460-9. PubMed ID: 17959934
[TBL] [Abstract][Full Text] [Related]
12. N-Epsilon-(carboxymethyl)lysine is unable to induce endothelial dysfunction but is able to attenuate Ages-induced endothelium damage in human umbilical vein endothelial cells.
Feng L; Zhu MM; Zhang MH; Jia XB
Pharmazie; 2013 Apr; 68(4):251-6. PubMed ID: 23700790
[TBL] [Abstract][Full Text] [Related]
13. Diabetes mellitus activates signal transduction pathways resulting in vascular endothelial growth factor resistance of human monocytes.
Tchaikovski V; Olieslagers S; Böhmer FD; Waltenberger J
Circulation; 2009 Jul; 120(2):150-9. PubMed ID: 19564559
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation.
Lin MT; Yen ML; Lin CY; Kuo ML
Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751
[TBL] [Abstract][Full Text] [Related]
15. ATL-1, an analogue of aspirin-triggered lipoxin A4, is a potent inhibitor of several steps in angiogenesis induced by vascular endothelial growth factor.
Cezar-de-Mello PF; Vieira AM; Nascimento-Silva V; Villela CG; Barja-Fidalgo C; Fierro IM
Br J Pharmacol; 2008 Mar; 153(5):956-65. PubMed ID: 18193074
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of vascular endothelial growth factor and advanced glycation end products in aqueous humor of patients with diabetic retinopathy.
Endo M; Yanagisawa K; Tsuchida K; Okamoto T; Matsushita T; Higuchi M; Matsuda A; Takeuchi M; Makita Z; Koike T
Horm Metab Res; 2001 May; 33(5):317-22. PubMed ID: 11440280
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms underlying somatostatin receptor 2 down-regulation of vascular endothelial growth factor expression in response to hypoxia in mouse retinal explants.
Mei S; Cammalleri M; Azara D; Casini G; Bagnoli P; Dal Monte M
J Pathol; 2012 Feb; 226(3):519-33. PubMed ID: 21960021
[TBL] [Abstract][Full Text] [Related]
18. Arginine attenuates methylglyoxal- and high glucose-induced endothelial dysfunction and oxidative stress by an endothelial nitric-oxide synthase-independent mechanism.
Dhar I; Dhar A; Wu L; Desai K
J Pharmacol Exp Ther; 2012 Jul; 342(1):196-204. PubMed ID: 22518022
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide.
Bussolati B; Dunk C; Grohman M; Kontos CD; Mason J; Ahmed A
Am J Pathol; 2001 Sep; 159(3):993-1008. PubMed ID: 11549592
[TBL] [Abstract][Full Text] [Related]
20. At least 2 distinct pathways generating reactive oxygen species mediate vascular cell adhesion molecule-1 induction by advanced glycation end products.
Basta G; Lazzerini G; Del Turco S; Ratto GM; Schmidt AM; De Caterina R
Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1401-7. PubMed ID: 15845907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
